07 / Common problems
Before we begin,
define responsibilities and boundaries.
The actual scope, costs, authority and delivery are governed by an agreement in writing signed by the parties.
Can we just buy one phase? +
An independent rapid screening, feasibility study or another applicable phase may be commissioned on its own. Buyer outreach in later phases requires the necessary preparation and authorization; the parties can review whether reliable work already completed may be reused.
Does market validation guarantee customers or orders? +
No. Market validation gathers verifiable evidence, identifies limitations and reduces premature spending; a buyer's refusal, lack of response or objection to price is also meaningful market evidence.
Can we use our factory brand to contact Canadian clients? +
Yes, after obtaining valid written authorization and checking the details. We may use manufacturer-approved branding and materials while clearly disclosing our role as an authorized representative. We do not imply the existence of a Canadian branch, stock or after-sales capability that is not actually in place.
Does Inspelis sign sales contracts or act as the importer? +
Not automatically. Our main role is market research, buyer contact and commercial coordination. Final quotations, contracting, importation, product quality and after-sales responsibilities must be assigned to the relevant parties in writing.
How does Inspelis charge? +
Fees are quoted for each assignment according to product complexity, target area, research depth, buyer-outreach needs and the agreed activity volume. Rapid screening, phased work and a 90-day pilot may each carry a fixed project fee agreed in advance. Third-party expenses such as travel, samples, testing and translation require advance approval. Ongoing sales representation, if subsequently commissioned, has a separate agreement covering any monthly retainer and transaction-based commission. We do not publish a standard price that has not been formally established.
Is the service still valuable if the recommendation is not to enter Canada? +
Yes. Evidence supporting a decision to defer, adjust or stop can help avoid unnecessary spending. We document the findings and limitations so the manufacturer can review the recommendation.
Why Choose Inspelis? +
Why would some companies pay thousands of dollars for a report? +
Some manufacturers commission market research to reduce uncertainty before committing larger budgets. The value depends on the questions addressed, the reliability of the evidence, the work performed and the usefulness of the recommendations—not the length of a report.